Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Concept Medical.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Concept Medical
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
5600 Mariner ST, STE 200, Tampa, FL 33609
Telephone
Telephone
+1(813)955-8855

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

FDA gave IDE approval for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fistula in the Haemodialysis management of Chronic Renal Failure.


Lead Product(s): Sirolimus

Therapeutic Area: Nephrology Product Name: MagicTouch AVF

Highest Development Status: IND EnablingProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 02, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The IDE approval will allow Concept Medical to initiate pivotal clinical study to demonstrate safety and effectiveness of the MagicTouch PTA Sirolimus coated balloon in femoral and popliteal segments for the treatment of Superficial Femoral Arteries.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MagicTouch PTA

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 29, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

MagicTouch SCB is the world’s first Sirolimus-coated Balloon with extensive commercial usage or for the treatment of Small Vessels (SV) in coronary arteries, in Europe, major markets of Asia and the Mid-Eastern markets.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MagicTouch SCB

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 28, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Magic Touch PTA is CE approved and commercially marketed sirolimus DCB, using proprietary Nanolute Technology – drug delivery technology platform of Magic Touch PTA balloon, is designed to deliver sub-micron particles of sirolimus to reach deepest layers of vessel walls.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 21, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Magic Touch PTA is a marketed sirolimus coated balloon, developed using proprietary Nanolute Technology– the drug delivery technology platform of Magic Touch PTA balloon, is designed to deliver sub-micron particles of sirolimus to reach the deepest layers of the vessel walls.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MagicTouch PTA

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Jena University Hospital

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 09, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Concept Medical Inc. focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon).


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MagicTouch

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 02, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

FUTURE BTK is a randomized, double blind, placebo-controlled, multi-center trial aimed at determining the effectiveness of MagicTouch PTA sirolimus coated balloon vs standard balloon angioplasty to treat below the knee arterial disease in critical limb ischemia patients.


Lead Product(s): Sirolimus

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MagicTouch – PTA

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 27, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY